Skip to main content
CELLULAR GOODS PLC logo

CELLULAR GOODS PLC — Investor Relations & Filings

Ticker · CBX ISIN · GB00BK964W87 LEI · 213800IXPX4Z2MKX2U28 IL Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2022-09-21 Regulatory Filings
Country GB United Kingdom
Listing IL CBX

About CELLULAR GOODS PLC

https://cellular-goods.com/

Cellular Goods PLC is a wellness company focused on developing consumer products using lab-grown, biosynthetic cannabinoids. The company's initial product lines included high-end skincare and topical athletic recovery solutions, utilizing cannabinoids like Cannabidiol (CBD) produced via cellular agriculture. This method aims to provide high-purity and sustainable ingredients. In early 2024, the company announced a strategic shift to focus on artificial intelligence applications within the beauty sector, leading to a proposed name change to Cel AI PLC.

Recent filings

Filing Released Lang Actions
Launch of three new skincare products
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 0590A' and is distributed via 'RNS, the news service of the London Stock Exchange.' It contains a 'Press Release' announcing the launch of new skincare products and the signing of a celebrity endorser. This format—a brief, timely announcement disseminated through the Regulatory Information Service (RNS) that contains material business updates but is not a comprehensive financial report (like 10-K or IR)—fits the definition of a general regulatory announcement or filing. Since it is a specific, non-financial operational announcement distributed via RNS, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such market news releases.
2022-09-21 English
Publication of new white paper
Regulatory Filings Classification · 99% confidence The document is identified by the RNS Number and the header 'RNS Number : 3533Y'. The content announces the 'Publication of white paper exploring the top-five benefits of cannabinoids for skincare applications'. It details the content of the white paper and provides a link to view it. Crucially, the document explicitly states at the end: 'Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature.' This indicates it is a press release or announcement about published material, not the full regulatory filing itself (like a 10-K or IR). Since it is an announcement about the publication of a specific document (a white paper), and it is distributed via the RNS/Reach system but explicitly marked as non-regulatory, the most appropriate classification is Report Publication Announcement (RPA), as it announces the release of a specific piece of company information/research. It is not a general regulatory filing (RNS) because it is specific about the publication event.
2022-09-06 English
Grant of Share Options
Remuneration Information Classification · 99% confidence The document is identified by the header 'RNS Number' and contains a 'Press release' dated 17 August 2022. The core content announces the 'Grant of Share Options' to two key employees (CSCO and Marketing Director). This type of announcement, detailing the issuance of options/shares to management/directors, falls under insider transactions or share-related corporate actions. Since it is a formal announcement distributed via RNS (London Stock Exchange's news service) and deals with the granting of options to executives, it is closely related to Director's Dealing (DIRS) or Share Issue/Capital Change (SHA). However, the specific action is the granting of options to executives, which is a form of insider transaction/remuneration disclosure, but the most fitting category for general insider transactions by directors is DIRS. Given the context of executive compensation/incentives via options, it is a specific type of insider activity. Since it is a formal regulatory announcement distributed via RNS, and the content is about executive share awards, it is best classified as a Regulatory Filing (RNS) if a more specific category doesn't perfectly fit. Let's re-evaluate the options: DIRS is for 'Director's Dealing' (personal share transactions). This is an award/grant by the company. SHA is for 'Share Issue/Capital Change'. This is an option grant, which affects capital structure upon exercise. DEF 14A is for 'Remuneration Information'. This is related to remuneration. Given the options, the announcement of share options granted to executives is a specific form of insider/management compensation disclosure. Since the document is a short, formal announcement distributed via RNS, and the content is about executive share awards, it is most accurately captured by the general regulatory announcement category (RNS) or potentially related to DIRS/DEF 14A. Since it is a grant of options (not a trade by the director), and it's a formal RNS release, RNS is the safest general classification, but let's check if DIRS or SHA is better. DIRS is for personal trades. SHA is for capital changes. This is an incentive grant. Given the structure and the RNS source, RNS is appropriate, but if we must choose a more specific corporate action, the closest is often related to insider activity or capital structure. Since this is a standard regulatory news service release (RNS), and it doesn't fit perfectly into the specific operational/financial reports, RNS is the most appropriate fallback for this type of mandatory disclosure.
2022-08-17 English
Appointment of new Chief Financial Officer
Board/Management Information Classification · 98% confidence The document is a press release disseminated via RNS (Regulatory Information Service) on August 16, 2022. The primary content announces the 'Appointment of new Chief Financial Officer' (Bruna Nikolla) and details the transition from the outgoing CFO. This type of announcement, concerning changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). Although it is distributed via RNS, the specific subject matter is management change, making MANG the most precise classification over the general RNS fallback.
2022-08-16 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is a short announcement (1932 chars) disseminated via RNS (Regulatory News Service) from the London Stock Exchange. The content explicitly discusses a 'Second Price Monitoring Extension' for a security, which is a specific operational notice related to trading halts or volatility controls. This type of immediate, non-periodic operational announcement that doesn't fit into standard financial reporting categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing (RNS), as per the definitions and the nature of the content being a market operational update.
2022-08-05 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1915 characters) and originates from 'RNS, the news service of the London Stock Exchange'. It announces a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory market announcement regarding trading procedures, not a comprehensive financial report or a standard corporate action like a dividend or management change. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIV, ER, 10-K, etc.), the most appropriate classification is the general regulatory filing fallback category.
2022-08-05 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.